Oconnor-A-Distinct-Business-Unit-Of-Ubs-Asset-Management-Americas

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
287
Total Value
1223796669
Accession Number
0001132716-25-000010
Form Type
13F-HR
Manager Name
Oconnor-A-Distinct-Business-Unit-Of-Ubs-Asset-Management-Americas
Data Enrichment
81% identified
232 identified55 unidentified

Holdings

287 positions • $1.2B total value
Manager:
Search and click to pin securities to the top
Page 9 of 15
TAPESTRY, INC.
Shares:15.0K
Value:$1.1M
% of Portfolio:0.1% ($1.1M/$1.2B)
Nuvation Bio Inc.
Shares:592.1K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
GAP INC
Shares:50.0K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
Merus N.V.
Shares:24.2K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
Mirum Pharmaceuticals, Inc.
Shares:22.6K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
KROGER CO
Shares:15.0K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
Praxis Precision Medicines, Inc.
Shares:26.8K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
Arcus Biosciences, Inc.
Shares:128.7K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
Relay Therapeutics, Inc.
Shares:382.9K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
KALA BIO, Inc.
Shares:170.9K
Value:$979.4K
% of Portfolio:0.1% ($979.4K/$1.2B)
COSTCO WHOLESALE CORP /NEW
Shares:1.0K
Value:$945.8K
% of Portfolio:0.1% ($945.8K/$1.2B)
Terns Pharmaceuticals, Inc.
Shares:336.1K
Value:$927.8K
% of Portfolio:0.1% ($927.8K/$1.2B)
Transocean Ltd.
Shares:803.4K
Value:$926.6K
% of Portfolio:0.1% ($926.6K/$1.2B)
Annexon, Inc.
Shares:466.8K
Value:$901.0K
% of Portfolio:0.1% ($901.0K/$1.2B)
Day One Biopharmaceuticals, Inc.
Shares:113.3K
Value:$898.1K
% of Portfolio:0.1% ($898.1K/$1.2B)
Scholar Rock Holding Corp
Shares:27.6K
Value:$887.9K
% of Portfolio:0.1% ($887.9K/$1.2B)
Aura Biosciences, Inc.
Shares:151.1K
Value:$885.5K
% of Portfolio:0.1% ($885.5K/$1.2B)
IQVIA HOLDINGS INC.
Shares:5.0K
Value:$881.5K
% of Portfolio:0.1% ($881.5K/$1.2B)
BridgeBio Pharma, Inc.
Shares:25.5K
Value:$881.3K
% of Portfolio:0.1% ($881.3K/$1.2B)
Edgewise Therapeutics, Inc.
Shares:40.0K
Value:$880.3K
% of Portfolio:0.1% ($880.3K/$1.2B)